Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies
Elisa ten Hacken, Rebecca Valentin, Fara Faye Regis, et al.
JCI Insight (2018) Vol. 3, Iss. 19
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Full-length transcript characterization of SF3B1 mutation in chronic lymphocytic leukemia reveals downregulation of retained introns
Alison D. Tang, Cameron M. Soulette, Marijke J. van Baren, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 390
Targeting mRNA processing as an anticancer strategy
Joana Desterro, Pedro Bak‐Gordon, Maria Carmo‐Fonseca
Nature Reviews Drug Discovery (2019) Vol. 19, Iss. 2, pp. 112-129
Closed Access | Times Cited: 161
Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
Maximilian Stahl, Kamal Menghrajani, Andriy Derkach, et al.
Blood Advances (2021) Vol. 5, Iss. 5, pp. 1552-1564
Open Access | Times Cited: 146
Altered RNA Processing in Cancer Pathogenesis and Therapy
Esther A. Obeng, Connor Stewart, Omar Abdel‐Wahab
Cancer Discovery (2019) Vol. 9, Iss. 11, pp. 1493-1510
Open Access | Times Cited: 126
Circular RNAs and RNA Splice Variants as Biomarkers for Prognosis and Therapeutic Response in the Liquid Biopsies of Lung Cancer Patients
Florence de Fraipont, Sylvie Gazzéri, William C. Cho, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 90
Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia
Eric Wang, Jose Mario Bello Pineda, Won Jun Kim, et al.
Cancer Cell (2022) Vol. 41, Iss. 1, pp. 164-180.e8
Open Access | Times Cited: 49
Pre-mRNA splicing-associated diseases and therapies
Sierra L. Love, Joseph D. Emerson, Kazunori Koide, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 525-538
Open Access | Times Cited: 26
Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML
Emily C. Wheeler, Benjamín Martín, William C. Doyle, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 728
Open Access | Times Cited: 15
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma ( MCL ) ‐ outcomes and mutation profile from venetoclax resistant MCL patients
Shuangtao Zhao, Rashmi Kanagal‐Shamanna, Lucy Navsaria, et al.
American Journal of Hematology (2020) Vol. 95, Iss. 6, pp. 623-629
Open Access | Times Cited: 66
RNA-binding proteins in hematopoiesis and hematological malignancy
Daniel J. Hodson, Michael Screen, Martin Turner
Blood (2019) Vol. 133, Iss. 22, pp. 2365-2373
Open Access | Times Cited: 57
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing
Prasath Pararajalingam, Krysta M. Coyle, Sarah E. Arthur, et al.
Blood (2020) Vol. 136, Iss. 5, pp. 572-584
Open Access | Times Cited: 52
METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL
Yiming Wu, Meiling Jin, Mike M. Fernandez, et al.
Blood Cancer Discovery (2023) Vol. 4, Iss. 3, pp. 228-245
Open Access | Times Cited: 17
Targeting the spliceosome machinery: A new therapeutic axis in cancer?
Béatrice Eymin
Biochemical Pharmacology (2020) Vol. 189, pp. 114039-114039
Closed Access | Times Cited: 42
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia
Steven Sher, Ethan C. Whipp, Janek S. Walker, et al.
Leukemia (2022) Vol. 37, Iss. 2, pp. 326-338
Open Access | Times Cited: 24
Emerging Therapies in CLL in the Era of Precision Medicine
Prajish Iyer, Lili Wang
Cancers (2023) Vol. 15, Iss. 5, pp. 1583-1583
Open Access | Times Cited: 15
Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities
Maxime Blijlevens, Jing Li, Victor W. van Beusechem
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5110-5110
Open Access | Times Cited: 30
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia
Charles Herbaux, Christoph Kornauth, Stéphanie Poulain, et al.
Blood (2021) Vol. 137, Iss. 25, pp. 3495-3506
Open Access | Times Cited: 28
Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model
Filippo Severin, Andrea Urbani, Tatiana Varanita, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 22
Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages
Paula Díez, Pablo Juanes‐Velasco, Marina L. García‐Vaquero, et al.
Molecular Oncology (2025)
Open Access
In VivoModeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
Elisa ten Hacken, Tomasz Sewastianik, Shanye Yin, et al.
Blood Cancer Discovery (2022) Vol. 4, Iss. 2, pp. 150-169
Open Access | Times Cited: 17
Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 Inhibition
Erhan Aptullahoglu, Carmela Ciardullo, Jonathan P. Wallis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2410-2410
Open Access | Times Cited: 10
DLBCL arising from indolent lymphomas: How are they different?
Erin M. Parry, Sandrine Roulland, Jessica Okosun
Seminars in Hematology (2023) Vol. 60, Iss. 5, pp. 277-284
Open Access | Times Cited: 9
Ceramide Analogue SACLAC Modulates Sphingolipid Levels and MCL-1 Splicing to Induce Apoptosis in Acute Myeloid Leukemia
Jennifer M. Pearson, Su‐Fern Tan, Arati Sharma, et al.
Molecular Cancer Research (2019) Vol. 18, Iss. 3, pp. 352-363
Open Access | Times Cited: 26
Cytokine-like protein 1–induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML
Margaux Sevin, Franck Debeurme, Lucie Laplane, et al.
Blood (2021) Vol. 137, Iss. 24, pp. 3390-3402
Open Access | Times Cited: 22
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia
Billy Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan, et al.
Blood (2021) Vol. 139, Iss. 6, pp. 859-875
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top